Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly LaDuca

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Molecular Genetics and Metabolism|July 20, 2010
Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU)Barbara K Burton, Heather Bausell, Rachel Katz, et al.
JCO Precision Oncology|January 20, 2022
RNA-Seq Analysis Is a Useful Tool in Variant ClassificationRachid Karam, Holly LaDuca, Marcy E Richardson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2017
Multigene Panel Testing Provides a New Perspective on Lynch SyndromeCarin R Espenschied, Holly LaDuca, Shuwei Li, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 29, 2018
Advocating for the consumer: clinical confirmation of all direct-to-consumer raw data alterations remains criticalStephany Tandy-Connor, Kate Krempely, Tina Pesaran, et al.
European Journal of Human Genetics : EJHG|March 19, 2026
Sequencing approaches in hereditary cancer testing: strengths, limitations and future directionsSami Belhadj, Christopher J Hatch, Holly LaDuca, et al.
JCO Precision Oncology|January 7, 2022
Different Fumarate Hydratase Gene Variants Are Associated With Distinct Cancer PhenotypesJunne Kamihara, Carrie Horton, Yuan Tian, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2018
Prevalence of Germline Mutations in Polyposis and Colorectal Cancer-Associated Genes in Patients With Multiple Colorectal PolypsPeter P Stanich, Rachel Pearlman, Alice Hinton, et al.
Cancer Genetics|October 19, 2016
Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriersTracey P Leedom, Holly LaDuca, Rachel McFarland, et al.
Cold Spring Harbor Molecular Case Studies|October 30, 2021
Classification of the canonical splice alteration <i>MUTYH</i> c.934-2A > G is likely benign based on RNA and clinical dataFelicia Hernandez, Blair R Conner, Marcy E Richardson, et al.
Familial Cancer|December 25, 2018
Monoallelic MUTYH carrier status is not associated with increased breast cancer risk in a multigene panel cohortKelly Fulk, Holly LaDuca, Mary Helen Black, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Molecular Genetics and Metabolism|July 20, 2010
Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU)Barbara K Burton, Heather Bausell, Rachel Katz, et al.
JCO Precision Oncology|January 20, 2022
RNA-Seq Analysis Is a Useful Tool in Variant ClassificationRachid Karam, Holly LaDuca, Marcy E Richardson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2017
Multigene Panel Testing Provides a New Perspective on Lynch SyndromeCarin R Espenschied, Holly LaDuca, Shuwei Li, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 29, 2018
Advocating for the consumer: clinical confirmation of all direct-to-consumer raw data alterations remains criticalStephany Tandy-Connor, Kate Krempely, Tina Pesaran, et al.
European Journal of Human Genetics : EJHG|March 19, 2026
Sequencing approaches in hereditary cancer testing: strengths, limitations and future directionsSami Belhadj, Christopher J Hatch, Holly LaDuca, et al.
JCO Precision Oncology|January 7, 2022
Different Fumarate Hydratase Gene Variants Are Associated With Distinct Cancer PhenotypesJunne Kamihara, Carrie Horton, Yuan Tian, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2018
Prevalence of Germline Mutations in Polyposis and Colorectal Cancer-Associated Genes in Patients With Multiple Colorectal PolypsPeter P Stanich, Rachel Pearlman, Alice Hinton, et al.
Cancer Genetics|October 19, 2016
Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriersTracey P Leedom, Holly LaDuca, Rachel McFarland, et al.
Cold Spring Harbor Molecular Case Studies|October 30, 2021
Classification of the canonical splice alteration <i>MUTYH</i> c.934-2A > G is likely benign based on RNA and clinical dataFelicia Hernandez, Blair R Conner, Marcy E Richardson, et al.
Familial Cancer|December 25, 2018
Monoallelic MUTYH carrier status is not associated with increased breast cancer risk in a multigene panel cohortKelly Fulk, Holly LaDuca, Mary Helen Black, et al.
Pageof 7